Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have remarkably improved the survival rate of patients with renal cell carcinoma (RCC), accompanied by higher hypertension (HTN) incidence among patients with RCC, reflecting the coming of a cardio-oncologic era. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ba, Zhengqing, Xiao, Ying, He, Ming, Liu, Dong, Wang, Hao, Liang, Hanyang, Yuan, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892205/
https://www.ncbi.nlm.nih.gov/pubmed/35252390
http://dx.doi.org/10.3389/fcvm.2022.810262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892205/
https://www.ncbi.nlm.nih.gov/pubmed/35252390
http://dx.doi.org/10.3389/fcvm.2022.810262

Ejemplares similares